INSERM Transfert
INSERM Transfert is the private subsidiary of INSERM – Institut national de la santé et de la recherche médicale (National Institute for Health and Medical Research – INSERM) – created in 2000 and operating under a Public Service Concession to support innovation and technology transfer in the life sciences. The organization manages the economic and societal value creation of INSERM’s research, offering access to expert scientists and clinicians as well as innovations from basic, translational, and clinical research. Its strategic focus areas include digital health, artificial intelligence, health data, and emerging therapeutic modalities such as antibodies and cell therapies.
Within IMPROVE PRETERM, INSERM Transfert supports project management, ethics, and administrative coordination, ensuring smooth collaboration across partners and compliance with European research and innovation standards. By bridging scientific expertise with operational excellence, INSERM Transfert plays a key role in guiding the project’s governance and enabling efficient, well-structured delivery of activities throughout the consortium.